ArticleFrontiers in neurology

Case Report: B-cell-targeted therapy with ofatumumab achieves remission in refractory panuveitis and coexisting multiple sclerosis.

Agni M Konitsioti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.